Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1984-10-25
1986-12-23
Daus, Donald G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514786, 514787, 546105, 558414, 558423, 558425, 558411, A61K 3147, C07D21910
Patent
active
046312862
ABSTRACT:
There are disclosed compounds having the formula ##STR1## wherein X is hydrogen, loweralkyl, loweralkoxy, halogen, hydroxy, nitro, NHCOR.sub.2 wherein R.sub.2 is loweralkyl, or a group of the formula NR.sub.3 R.sub.4 wherein R.sub.3 and R.sub.4 are independently hydrogen or loweralkyl; R and R.sub.1 are independently hydrogen, loweralkyl, phenylloweralkyl, phenylloweralkyl in which the phenyl group is substituted by one or more loweralkyl, loweralkoxy, halogen, hydroxy or trifluoromethyl, diphenylloweralkyl or diphenylloweralkyl in which one or both phenyl groups are substituted by one or more loweralkyl, loweralkoxy, halogen, hydroxy or trifluoromethyl; Y is C.dbd.O or CR.sub.5 OH wherein R.sub.5 is hydrogen or loweralkyl; Z is CH.sub.2 or C.dbd.CR.sub.6 R.sub.7 wherein R.sub.6 and R.sub.7 are independently hydrogen or loweralkyl; or Y and Z taken together is CR.sub.5 .dbd.CH wherein CR.sub.5 and CH correspond to Y and Z respectively; an optical antipode thereof, or a pharmaceutically acceptable acid addition salt thereof, which are useful for enhancing memory, methods for synthesizing them, and pharmaceutical compositions comprising an effective memory enhancing amount of such a compound.
REFERENCES:
patent: 3033866 (1962-05-01), Saggiomo et al.
patent: 3122553 (1964-02-01), Seneca
patent: 3232945 (1966-02-01), Sigal, Jr. et al.
patent: 4284627 (1981-08-01), Raether et al.
Magidson, et al., Chemical Abstracts, vol. 31, 5800.sup.7 (1937).
Sargent, et al., J. Org. Chem., vol. 11, pp. 350-362 (1946).
Sargent, et al., J. Org. Chem., vol. 12, pp. 567-570 (1947).
Sargent, et al., J. Org. Chem., vol. 12, pp. 571-576 (1947).
Stephen, et al., J. Chem. Soc. (1947), pp. 1034-1039.
Desai, et al., J. Indian Chem. Soc., vol. 37, No. 9, pp. 553-556 (1960).
Steinberg, et al., J. Med. Chem., vol. 18, No. 11, pp. 1056-1061 (1975).
Brian, et al., Chemical Abstracts, vol. 62, 6459e (1965).
Albert, The Acridines, 2nd ed., St Martins Press, N.Y. (1966), pp. 431-432.
Patnaik, et al., J. Med. Chem., vol. 9, pp. 483-488 (1966).
Konshin, et al., Chemical Abstracts, vol. 76, 34080k (1972).
Konshin, et al., (T'), Chemical Abstracts, vol. 81, 120411d (1974).
Koupilova, et al., Chemical Abstracts, vol. 96, 155388p (1982).
Davies, Drug Development Research, vol. 5, pp. 69-76 (1985).
Johns, et al., Drug Development Research, vol. 5, pp. 77-96 (1985).
Ellman, et al., Biochemical Pharmacology, vol. 7, pp. 88-95 (1961).
Schindler, et al., Drug Development Research, vol. 4, pp. 567-576 (1984).
Bartus, et al., Science, vol. 209, pp. 301-303 (07/11/80).
Broekkamp, et al., Psychopharmacology, vol. 83, pp. 122-125 (1984).
Komiskey, et al., Psychopharmacology, vol. 73, pp. 304-305 (1981).
Pierrat Frank A.
Shutske Gregory M.
Daus Donald G.
Hoechst-Roussel Pharmaceuticals Inc.
Ikeda Tatsuya
Rivers Diana G.
LandOfFree
9-amino-1,2,3,4-tetrahydroacridin-1-ol and related compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 9-amino-1,2,3,4-tetrahydroacridin-1-ol and related compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 9-amino-1,2,3,4-tetrahydroacridin-1-ol and related compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-171953